Adult Patients with Cancer Have Impaired Humoral Responses to Complete and Booster COVID-19 Vaccination, Especially Those with Hematologic Cancer on Active Treatment: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Taking into consideration the high risk of patients with cancer for severe COVID-19 infection, prioritization has been given to primary prevention with both primary and booster vaccination. However, robust evidence for vaccination efficacy remains limited, due to the lack of availabl...

Descripción completa

Detalles Bibliográficos
Autores principales: Liatsou, Efstathia, Ntanasis-Stathopoulos, Ioannis, Lykos, Stavros, Ntanasis-Stathopoulos, Anastasios, Gavriatopoulou, Maria, Psaltopoulou, Theodora, Sergentanis, Theodoros N., Terpos, Evangelos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136728/
https://www.ncbi.nlm.nih.gov/pubmed/37190194
http://dx.doi.org/10.3390/cancers15082266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136728/
https://www.ncbi.nlm.nih.gov/pubmed/37190194
http://dx.doi.org/10.3390/cancers15082266

Ejemplares similares